Preferências e práticas de ortopedistas brasileiros por técnicas de tromboprofilaxia na artroplastia total do joelho: Levantamento entre membros da Sociedade Brasileira de Cirurgia do Joelho (SBCJ)

 

 Permissions and Reprints

Resumo

Objetivo Descrever as preferências e práticas atuais de uma amostra de cirurgiões de joelho do Brasil quanto à forma de tromboprofilaxia na artroplastia total do joelho (ATJ).

Método Na presente pesquisa realizada pela internet, cirurgiões associados à Sociedade Brasileira de Cirurgia do Joelho (SBCJ) foram convidados a responder voluntariamente a um questionário anônimo incluindo o tempo de experiência cirúrgica pessoal, percepções sobre as melhores opções de tromboprofilaxia e as reais práticas no ambiente onde trabalham.

Resultados Entre dezembro de 2020 e janeiro de 2021, 243 participantes responderam ao questionário completo. Exceto por 3 (1,2%) participantes, todos declararam praticar tromboprofilaxia, a maioria (76%) combinando as formas farmacológica e mecânica. A droga mais prescrita é a enoxaparina (87%), com modificação para rivaroxabana (65%) após a alta. O momento de início da tromboprofilaxia variou conforme o tempo de formação do cirurgião de joelho (p ≤ 0,03) e as preferências e práticas variaram conforme a região do país (p < 0,05) e o sistema de saúde no qual trabalham os cirurgiões (público ou privado; p = 0,024). A opção por tromboprofilaxia mecânica também dependeu do tempo de formação do cirurgião.

Conclusão As preferências e práticas de tromboprofilaxia na ATJ são diversas nas regiões do Brasil e sistemas de saúde (público ou privado). Dada a inexistência de uma diretriz clínica nacional, a maior parte dos ortopedistas segue ou a diretriz de seu próprio hospital ou nenhuma. O método de profilaxia mecânica e a pouca utilização do ácido acetilsalicílico são os pontos que mais destoam das diretrizes e práticas internacionais.

Suporte Financeiro

O presente estudo não recebeu nenhum suporte financeiro de fontes públicas, comerciais ou sem fins lucrativos.

^* Trabalho desenvolvido na Faculdade de Medicina da Universidade Federal do Pará, Campus Belém.

Publication History

Received: 14 October 2021

Accepted: 31 January 2022

Article published online:
01 August 2022

© 2022. Sociedade Brasileira de Ortopedia e Traumatologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

• Referências

• 1 Falck-Ytter Y, Francis CW, Johanson NA. et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e278S-e325S
  CrossrefPubMedGoogle Scholar
• 2 Jacobs JJ, Mont MA, Bozic KJ. et al. American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Bone Joint Surg Am 2012; 94 (08) 746-747
  CrossrefPubMedGoogle Scholar
• 3 Anderson DR, Morgano GP, Bennett C. et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv 2019; 3 (23) 3898-3944
  CrossrefPubMedGoogle Scholar
• 4 Samama CM, Afshari A. AESA; VTE Guidelines Task Force. European guidelines on perioperative venous thromboembolism prophylaxis. Eur J Anaesthesiol 2018; 35 (02) 73-76
  CrossrefPubMedGoogle Scholar
• 5 Eysenbach G. Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res 2004; 6 (03) e34
  CrossrefPubMedGoogle Scholar
• 6 Almeida RF, Queiroz AA, Belloti JC, Castro Filho JM, Cohen M, Navarro RD. Approach towards total knee arthroplasty in Brazil: cross-sectional study. Sao Paulo Med J 2009; 127 (04) 190-197
  CrossrefPubMedGoogle Scholar
• 7 Erduran M, Akseki D, Araç S. Surgical practices in total knee arthroplasty in Turkey. Acta Orthop Traumatol Turc 2012; 46 (04) 255-261
  CrossrefPubMedGoogle Scholar
• 8 Mirkazemi C, Bereznicki LR, Peterson GM. Comparing Australian orthopaedic surgeons' reported use of thromboprophylaxis following arthroplasty in 2012 and 2017. BMC Musculoskelet Disord 2019; 20 (01) 57
  CrossrefPubMedGoogle Scholar
• 9 Excellence NIfHaC. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. Updated August 2019. Accessed 2021 Aug 08, 2020 https:/www.nice.org.uk/guidance/ng89
  PubMedGoogle Scholar
• 10 Liu F, Chu X, Huang J, Tian K, Hua J, Tong P. Administration of enoxaparin 24 h after total knee arthroplasty: safer for bleeding and equally effective for deep venous thrombosis prevention. Arch Orthop Trauma Surg 2014; 134 (05) 679-683
  CrossrefPubMedGoogle Scholar
• 11 Plante S, Belzile EL, Fréchette D, Lefebvre J. Analysis of contributing factors influencing thromboembolic events after total knee arthroplasty. Can J Surg 2017; 60 (01) 30-36
  CrossrefPubMedGoogle Scholar
• 12 Runner RP, Gottschalk MB, Staley CA, Pour AE, Roberson JR. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates. J Arthroplasty 2019; 34 (04) 729-734
  CrossrefPubMedGoogle Scholar
• 13 Hunt LP, Ben-Shlomo Y, Whitehouse MR, Porter ML, Blom AW. The Main Cause of Death Following Primary Total Hip and Knee Replacement for Osteoarthritis: A Cohort Study of 26,766 Deaths Following 332,734 Hip Replacements and 29,802 Deaths Following 384,291 Knee Replacements. J Bone Joint Surg Am 2017; 99 (07) 565-575
  CrossrefPubMedGoogle Scholar
• 14 Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 2000; 355 (9212): 1295-1302
  CrossrefPubMedGoogle Scholar
• 15 Anderson DR, Dunbar M, Murnaghan J. et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med 2018; 378 (08) 699-707
  CrossrefPubMedGoogle Scholar
• 16 Farey JE, An VVG, Sidhu V, Karunaratne S, Harris IA. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis. Orthop Traumatol Surg Res 2021; 107 (01) 102606
  CrossrefPubMedGoogle Scholar
• 17 Haykal T, Kheiri B, Zayed Y. et al. Aspirin for venous thromboembolism prophylaxis after hip or knee arthroplasty: An updated meta-analysis of randomized controlled trials. J Orthop 2019; 16 (04) 312-319
  CrossrefPubMedGoogle Scholar
• 18 Matharu GS, Kunutsor SK, Judge A, Blom AW, Whitehouse MR. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Intern Med 2020; 180 (03) 376-384
  CrossrefPubMedGoogle Scholar
• 19 Gali JC, Camargo DB. Thromboprophylaxis for Total Knee Arthroplasty. Rev Bras Ortop (Sao Paulo) 2019; 54 (01) 1-5
  Google Scholar
• 20 Chandrasekaran S, Ariaretnam SK, Tsung J, Dickison D. Early mobilization after total knee replacement reduces the incidence of deep venous thrombosis. ANZ J Surg 2009; 79 (7-8): 526-529
  CrossrefPubMedGoogle Scholar
• 21 Pearse EO, Caldwell BF, Lockwood RJ, Hollard J. Early mobilisation after conventional knee replacement may reduce the risk of postoperative venous thromboembolism. J Bone Joint Surg Br 2007; 89 (03) 316-322
  CrossrefPubMedGoogle Scholar
• 22 Elkassabany NM, Cai LF, Badiola I. et al. A prospective randomized open-label study of single injection versus continuous adductor canal block for postoperative analgesia after total knee arthroplasty. Bone Joint J 2019; 101-B (03) 340-347
  CrossrefPubMedGoogle Scholar
• 23 Li D, Tan Z, Kang P, Shen B, Pei F. Effects of multi-site infiltration analgesia on pain management and early rehabilitation compared with femoral nerve or adductor canal block for patients undergoing total knee arthroplasty: a prospective randomized controlled trial. Int Orthop 2017; 41 (01) 75-83
  CrossrefPubMedGoogle Scholar
• 24 Shalhoub J, Lawton R, Hudson J. et al; GAPS trial investigators. Graduated compression stockings as adjuvant to pharmaco-thromboprophylaxis in elective surgical patients (GAPS study): randomised controlled trial. BMJ 2020; 369: m1309
  CrossrefPubMedGoogle Scholar
• 25 Wang D, Bao F, Li Q, Teng Y, Li J. Semiautomatic intermittent pneumatic compression device applied to deep vein thrombosis in major orthopedic surgery. Biomed Eng Online 2018; 17 (01) 78
  CrossrefPubMedGoogle Scholar
• 26 He ML, Xiao ZM, Lei M, Li TS, Wu H, Liao J. Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty. Cochrane Database Syst Rev 2014; (07) CD008207
  PubMedGoogle Scholar
• 27 Kahn SR, Shivakumar S. What's new in VTE risk and prevention in orthopedic surgery. Res Pract Thromb Haemost 2020; 4 (03) 366-376
  CrossrefPubMedGoogle Scholar
• 28 Parvizi J, Huang R, Rezapoor M, Bagheri B, Maltenfort MG. Individualized Risk Model for Venous Thromboembolism After Total Joint Arthroplasty. J Arthroplasty 2016; 31 (9, Suppl): 180-186
  CrossrefPubMedGoogle Scholar
• 29 Viana LMAT, Nogueira IAL, Fontenele AMM, Oliveira LP. Thromboembolism in Arthroplasty: Compliance to Prophylaxis. Rev Bras Ortop (Sao Paulo) 2021; 56 (05) 647-655
  Google Scholar
• 30 Carvalho Júnior LH, Correa MA, Lima MR, Silvestre CB, Almeida VF, Temponi EF. Venous Thromboembolism Prevention Protocol: Experience of 2,000 Cases in Total Knee Arthroplasty. Rev Bras Ortop (Sao Paulo) 2020; 55 (04) 426-431
  Article in Thieme ConnectPubMedGoogle Scholar

• Supplementary Material